dc.contributor.author |
Pillaiyar, Thanigaimalai |
|
dc.date.accessioned |
2022-06-21T10:27:21Z |
|
dc.date.available |
2022-06-21T10:27:21Z |
|
dc.date.issued |
2022 |
|
dc.identifier.issn |
0365-6233 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/128164 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Weinheim |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1002/ardp.202100367 |
de_DE |
dc.subject.ddc |
540 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID-19 |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20220404000000_00471 |
|
utue.personen.roh |
Manickam, Manoj |
|
utue.personen.roh |
Meenakshisundaram, Sangeetha |
|
utue.personen.roh |
Pillaiyar, Thanigaimalai |
|
dcterms.isPartOf.ZSTitelID |
Archiv der Pharmazie |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 2100367 |
de_DE |
dcterms.isPartOf.ZS-Volume |
355 (3) |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
de_DE |